11UK
Structure of SARS-CoV-2 variant LP.8.1 spike protein
Summary for 11UK
| Entry DOI | 10.2210/pdb11uk/pdb |
| EMDB information | 76062 |
| Descriptor | Spike glycoprotein, beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, ... (4 entities in total) |
| Functional Keywords | sars-cov-2, spike ectodomain, viral protein |
| Biological source | Severe acute respiratory syndrome coronavirus 2 |
| Total number of polymer chains | 3 |
| Total formula weight | 435261.44 |
| Authors | |
| Primary citation | Nasir, A.,Lee, D.W.,Wang, Z.,Ogega, C.,Bopp, N.,Wisti, P.,Makrinos, D.,Jani, H.,Gorrie, A.,Bender, M.F.,Laciak, A.R.,Sharma, A.,Hu, X.,Speidel, T.,Ghantous, F.,Berrueta, D.M.,Hou, Y.J.,Severson, M.,Langley, A.,Hardcastle, K.,Elbashir, S.,Harmon, C.,Amato, N.J.,Wu, K.,Schief, W.R.,Hohn, K.,Carfi, A.,Budigi, Y.,Wahid, R.,Edwards, D.K.,Freyn, A.W. mRNA-1273.251 and mRNA-1283.251 vaccines expressing SARS-CoV-2 variant LP.8.1 antigens broadly neutralize JN.1-lineage viruses Mol Ther Nucleic Acids, 2026 Cited by DOI: 10.1016/j.omtn.2026.103178PDB entries with the same primary citation |
| Experimental method | ELECTRON MICROSCOPY (2.64 Å) |
Structure validation
Download full validation report






